05 March 2019 : Case report
Pure Red Cell Aplasia After Kidney Transplantation: Parvovirus B19 Culprit or Coincidence?
Krzysztof Pabisiak1BCDEF*, Joanna Stępniewska1BEF, Kazimierz Ciechanowski1EFGDOI: 10.12659/AOT.913663
Ann Transplant 2019; 24:123-131
Abstract
BACKGROUND: Anemia is present even in long-term observation after kidney transplantation. Observational study results indicate the presence of chronic post-transplant anemia in one in three recipients. An extreme form of erythroid line dysfunction is pure red blood cell aplasia (PRCA).
CASE REPORT: PRCA may appear during immunosuppressive treatment irrespective of the kind of protocol and the transplanted organ. It may be caused by immunosuppressive treatment per se or its side effect,opportunistic pathogen activation. Parvovirus B19 (PV B19) infection is quite likely the cause of refractory normocytic anemia in immunocompromised patients.
CONCLUSIONS: Based on two PRCA cases in kidney transplant recipients the current views on the viral pathogenesis of this phenomenon and proposed treatment strategies have been discussed.
Keywords: Kidney Transplantation, Parvovirus B19, Human, Red-Cell Aplasia, Pure, Erythema Infectiosum, Immunocompromised Host, Postoperative Complications, Renal Insufficiency, Chronic, transplant recipients
Most Viewed Current Articles
15 Aug 2023 : Review article 7,203
Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ TransplantationDOI :10.12659/AOT.939750
Ann Transplant 2023; 28:e939750
03 Jan 2023 : Original article 7,086
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and...DOI :10.12659/AOT.938467
Ann Transplant 2023; 28:e938467
16 May 2023 : Original article 6,914
Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections ...DOI :10.12659/AOT.939258
Ann Transplant 2023; 28:e939258
28 May 2024 : Original article 6,394
Effect of Dexmedetomidine Combined with Remifentanil on Emergence Agitation During Awakening from Sevoflura...DOI :10.12659/AOT.943281
Ann Transplant 2024; 29:e943281